Cardiovascular and Prothrombotic Risk in Patients With Oral Lichen Planus.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: blood sample collection.
- Who it may be relevant to
- Registry conditions: Oral Lichen Planus. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Prospective Single-center Study of a Cohort of Patients With Oral Lichen Planus: Cardiovascular and Prothrombotic Risk in Patients With Oral Lichen Planus (OLP).
Overview
The primary objective is to evaluate the cardiovascular profile and the risk of thrombotic events in patients affected by Oral Lichen Planus.
Detailed description
Evaluation of thrombophilia screening parameters, antiphospholipid antibody levels, and platelet aggregability in a cohort of patients affected by Oral Lichen Planus.
Interventions
- Other blood sample collection
blood sample collection in old patients in order to study the trombophilic risk
Primary outcome measures
- Prothrombotic risk evaluation [Time frame: From September 2025 to September 2026]
Eligibility criteria
Inclusion criteria
- Patients with a clinical and histological diagnosis of Oral Lichen Planus
- Age > 18 years
- Patients who agree to sign the informed consent form
Exclusion criteria
- Patients under 18 years of age
- Patients who do not agree to sign the informed consent form
- Patients without a diagnosis of Oral Lichen Planus
- Patients with previously known cardiac diseases
- History of major cardiovascular events (myocardial infarction, ischemic stroke, TIA)
- Patients with overt heart failure (NYHA class III-IV)
- Cardiomyopathies not related to the studied risk factors (e.g., genetic hypertrophic cardiomyopathy)
- Patients undergoing anticoagulant therapy
- Patients with primary or secondary conditions associated with increased cardiovascular risk
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07151014 · 7635